Published 15 hours ago • loading... • Updated 15 hours ago

10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood

On Saturday, April 18, 2026, 10x Genomics Inc announced Atera, a new in situ spatial biology platform engineered to deliver whole-transcriptome spatial analysis with single-cell sensitivity at unprecedented scale, debuting at the AACR Annual Meeting.
Chief Technology Officer Michael Schnall-Levin said Atera "reflects a first-principles approach to solving a core challenge in biology." The system was rethought from the ground up, optimizing chemistry, hardware, and software for spatial analysis.
Poster #7116 highlights Atera's ability to overcome cost and workflow limitations for clinical-scale studies. Instructor Andrew Rech of the Carl June Lab said, "Using Atera has been extremely exciting for advancing our studies" of rare glioblastoma patient samples.
The platform is expected to begin shipping in the second half of 2026. Kevin Wei, MD, PhD at Brigham and Women's Hospital noted Atera "represents a significant step forward for spatial biology" to accelerate target discovery.
Bioptimus plans to expand to Atera in 2027 as throughput increases, positioning the platform for broader research scale. Chief Executive Officer Serge Saxonov stated the mission is "to accelerate the mastery of biology to advance human health.

Insights by Ground AI